Identification of risk profiles for liver injury in adults with multiple sclerosis using artificial intelligence method
Authors:
Open Access
- 4 October 2025
- journal article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 104, 106785
Abstract
No abstract availableKeywords
Funding Information
- Sanofi
This publication has 24 references indexed in Scilit:
- Diabetes as a risk factor for MASH progressionDiabetes Research and Clinical Practice, 2024
- Validity of ICD‐9 and ICD‐10 codes used to identify acute liver injury: A study in three European data sourcesPharmacoepidemiology and Drug Safety, 2019
- EASL Clinical Practice Guidelines: Drug-induced liver injuryJournal of Hepatology, 2019
- Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countriesJournal of Neurology, 2019
- Multiple sclerosis – a reviewEuropean Journal of Neurology, 2018
- IL-6 pathway in the liver: From physiopathology to therapyJournal of Hepatology, 2016
- Validity of diagnostic codes and laboratory measurements to identify patients with idiopathic acute liver injury in a hospital databasePharmacoepidemiology and Drug Safety, 2015
- Liver abnormalities in drug and substance abusersBest Practice & Research Clinical Gastroenterology, 2013
- Validity of diagnostic codes to identify cases of severe acute liver injury in the U.S. Food and Drug Administration's Mini‐Sentinel Distributed DatabasePharmacoepidemiology and Drug Safety, 2013
- Psychiatric Issues in Multiple SclerosisPsychiatric Clinics of North America, 2007